Personalised to support your treatment decisions

Find disease awareness content and supporting materials, including relevant drugs

Welcome:

Updates in your area
of interest

Articles your peers
are looking at

Bookmarks
saved

Days to your
next event

Learning Zones

UCB EHSF 2024 teaser tile image of 'medical summit'

Learning Zone Homepage

Advances in HS

30 mins

Learning Zone Homepage

All Things Angioedema and Urticaria: Podcasts

30 mins

3d rendered medically accurate illustration of a womans large intestine

Learning Zone Homepage

Ulcerative colitis Learning Zone

90 mins

Learning Zone Homepage

Psoriasis Academy

910 mins

Learning Zone Homepage

Alopecia areata Learning Zone

60 mins

Learning Zone Homepage

mCRPC in focus

110 mins

Pediatric Eosinophilic Esophagitis teaser image

Learning Zone

Type 2 Inflammation in Gastroenterology

160 mins

Learning Zone Homepage

Pediatric Atopic Dermatitis

30 mins

Myocardium Cardiac muscle fibers banner image

Learning Zone Homepage

Pompe Disease: Key findings from WMS 2022

150 mins

Doctor holding patients hand in consultation

Learning Zone Homepage

Supportive care in oncology Learning Zone

150 mins

Learning Zone Homepage

Albumin in fluid management

115 mins

Learning Zone Homepage

Glaucoma Learning Zone

190 mins

Image of AI generated blood clot formation that would require pharmacological treatments available for various vascular conditions, such as anticoagulants, anti platelet agents, and vasodilators

Learning Zone Homepage

Antiplatelet therapy in ACS: Choices and Controversies

270 mins

patient receiving dialysis, hospital image

Learning Zone Homepage

Chronic Kidney Disease Learning Zone

340 mins

Learning Zone Homepage

Hidradenitis suppurativa

220 mins

Learning Zone Homepage

Multiple Sclerosis (MS) Learning Zone

160 mins

Food Allergy_Selection of foods and allergies

Learning Zone Homepage

Food Allergy Learning Zone

280 mins

Learning Zone Homepage

Inflammatory Bowel Disease Learning Zone

100 mins

Improving treatment options for child psoriasis banner image, child and doctor

Learning Zone Homepage

Improving treatment options for childhood psoriasis

270 mins

Learning Zone

CDK4/6 inhibitors in breast cancer

199 mins

Learning Zone Homepage

Fibrinogen Deficiency in Bleeding Learning Zone

160 mins

Learning Zone Homepage

Oral Anticoagulation Reversal Learning Zone

355 mins

Webinars

Live roundtable

mCRPC update: Best practice and new insights

1 mins

Anti-CGRP advances in migraine treatment

Learning Zone

Anti-CGRPs in migraine management

60 mins

Learning Zone

Recurrence in early breast cancer

40 mins

Latest news

Drug news

FDA Advisory Committee recommended that anti-amyloid donanemab is effective for the treatment of patients with early symptomatic Alzheimer's disease

An 11-member advisory panel to the FDA has unanimously concluded that the investigational anti-amyloid donanemab is effective for the treatment of patients with early symptomatic Alzheimer's disease (AD) and that the potential benefits outweigh the risks in this patient population

1 mins

Drug news

Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase III

Data from the IMROZ phase III study demonstrated Sarclisa (isatuximab) in combination with standard-of-care bortezomib, lenalidomide and dexamethasone (VRd) followed by Sarclisa-Rd (the IMROZ regimen) significantly reduced the risk of disease progression or death by 40%, compared to VRd followed by Rd in patients with newly diagnosed multiple myeloma (NDMM) not eligible for transplant

1 min

Drug news

Safety and efficacy profile of Lupkynis (voclosporin) for people with lupus nephritis presented at EuropeanAlliance of Associations for Rheumatology Congress (EULAR)

Aurinia Pharmaceuticals Inc. announced an oral presentation at the European Alliance of Associations for Rheumatology (EULA R) 2024 taking place in Vienna, Austria June 12th - 15th

1 min

See all news